ANALYSIS RESULTS OF COMBINED TREATMENT OF PATIENTS WITH VERIFIED CANCER OF THE CERVICAL ESOPHAGUS AND HYPOPHARYNX WITH THE APPLICATION OF SURGICAL TREATMENT WITH ONE-STAGE DEFECT’S PLASTIC

In the treatment of many unresolved issues, indicating the need for research aimed at finding more effective treatment approaches. The aim of the study is to analyze the results of combined treatment of patients with widespread forms of cancer of the cervical esophagus and hypopharynx with the application of surgical treatment in the amount of pharyngolaryngitis with single-step plastic of the defect. A retrospective analysis of results of combined treatment of 28 patients with a verified diagnosis of cancer of the cervical esophagus and hypopharynx. Combined treatment of patients with cancer of the cervical esophagus and hypopharynx included the following treatments: induction chemoradiotherapy according to the scheme cisplatin/5-fluorouracil, external beam radiation therapy 65 Gy, brachytherapy (7 Gy 1 time per week, 3 sessions), surgical treatment with one-stage plastic of the esophagus. In 7 patients (25 %) was achieved complete regression on the background of induction chemotherapy, 21 patients (75 %) received the treatment in full. Postoperative mortality rate was of 9.52 %, post-operative complications such as anastomosis dehiscence – 19 %.

1. Чиссов В.И., Старинский В.В., Петрова Г.В., Злокачественные новообразования в России в 2008 году (заболеваемость и смертность). М., 2010. 256 с. [Chissov V.I., Starinskiy V.V., Petrova G.V. Malignant neoplasms in Russia in 2008 (morbidity and mortality). Moscow, 2010. 256 p. (In Russ.)].

2. Мерабишвили В.М. Выживаемость онкологических больных. Вып. 2, ч. 1. СПб., 2011. [Merabishvili V.M. Survival of cancer patients. Vol. 2, part 1. Saint Petersburg, 2011. (In Russ.)].

3. Давыдов М.И., Стилиди И.С. Рак пищевода. М.: Практическая медицина, 2007. С. 20–5. [Davydov M.I., Stilidi I.S. Esophageal cancer. Moscow: Prakticheskaya meditsina, 2007. Pp. 20–5. (In Russ.)].

4. Malaisrie S.C., Untch B., Aranha G.V. et al. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution. Arch Surg 2004;139(5):532–8.

5. Schwer A.L., Ballonoff A., McCammon R.J. et al. Survival effect of neoadjuvant radio- therapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study. Int J Radiat Oncol Biol Phys 2009;73(2):449–55. DOI: 10.1016/j.ijrobp.2008.04.022.

6. NCCN Clinical Practice Guidelines in Oncology. Esophageal and esophagogastric junction cancers. Version 2. 2016.

7. Минимальные клинические рекомендации Eвропейского общества медицинской онкологии (ESMO). Под ред.: С.А. Тюляндина, Д.А. Носова, Н.И. Переводчиковой. М., 2010. 436 с. [Minimal clinical recommendations of the European Society for Medical Oncology (ESMO). Eds. by: S.A. Tyulyandin, D.A. Nosova, N.I. Perevodchikova. Moscow, 2010. 436 p. (In Russ.)].

8. Mattioli F., Bettini M., Molteni G., Piccinini A. et al. Analysis of risk factors for pharingocutaneus fistula after total laryngectomy with particular focus on nutritional status. Acta Otorhinolaryngol Ital 2015;35(4):243–8.